KPV is a tripeptide fragment derived from the C-terminal region of α-melanocyte-stimulating hormone (α-MSH). It has been studied for its role in modulating inflammatory signaling pathways, particularly through interactions with melanocortin receptors and downstream effects on NF-κB activity.
In preclinical research models, KPV has demonstrated the ability to influence cytokine expression and cellular responses associated with inflammation. Its small molecular structure contributes to favorable stability and potential for localized application in experimental settings.
KPV is commonly investigated in studies focused on:
-
Inflammatory pathway modulation
-
Epithelial and barrier tissue responses
-
Cytokine signaling dynamics
This compound is intended strictly for laboratory research purposes only (FRPO) and is not for human consumption.




